Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16257635 | 0.86 | GLP1R (0.47) | GLP1RFAAHMEN1KMT2ATSHR | |
| SCHEMBL14685794 | 0.85 | GLP1R (0.48) | GLP1RMEN1KMT2ATSHRRECQL | |
| SCHEMBL25651302 | 0.85 | GLP1R (0.45) | GLP1RFAAHMEN1KMT2A | |
| SCHEMBL15259289 | 0.84 | GLP1R (0.46) | GLP1RFAAHMEN1KMT2ATSHR | |
| SCHEMBL12743611 | 0.81 | GLP1R (0.46) | GLP1RFAAHMEN1KMT2ATSHR | |
| SCHEMBL12807268 | 0.81 | GLP1R (0.46) | GLP1RFAAHMEN1KMT2ATSHR | |
| SCHEMBL1619320 | 0.80 | TSHR (0.43) | GLP1RFAAHMEN1KMT2ATSHR | |
| SCHEMBL14685783 | 0.79 | GLP1R (0.54) | GLP1RFAAHMEN1KMT2ATSHR | |
| SCHEMBL25465163 | 0.79 | GLP1R (0.62) | GLP1R | |
| SCHEMBL13880567 | 0.79 | GLP1R (0.62) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090111730-A1 | Polypeptide protracting tags | NOVO NORDISK A/S (DK) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111730-A1 | Polypeptide protracting tags | LNPEP, FGB, ENPEP | GLP1R 70/4885FAAH 2903/4885MEN1 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.